Section 8.3: Mixed Venous-Arterial Ulcers & Lymphedema

Section 8.3: Mixed Venous-Arterial Ulcers & Lymphedema

In clinical wound care practice, lower extremity ulcers do not always present as isolated single-etiology entities. Approximately 15% to 30% of leg ulcers exhibit a mixed venous-arterial etiology, combining the fluid overload of chronic venous insufficiency (CVI) with the ischemia of peripheral artery disease (PAD). Managing mixed ulcers requires precise vascular diagnostic stratification to deliver safe, modified compression. Furthermore, clinicians must distinguish chronic venous edema from lymphedema and phlebolymphedema. For the CWS exam, candidates must understand ABI threshold safety rules, lymphedema pathophysiology, pathognomonic physical exam signs, and Complete Decongestive Therapy principles.

---

Mixed Venous-Arterial Ulcers

Mixed venous-arterial leg ulcers (MVULs) occur when a patient with underlying chronic venous hypertension develops concomitant lower extremity arterial disease.

Clinical Presentation & Diagnostic Challenge

Patients with mixed ulcers often present with clinical features of both conditions: edema, hemosiderin staining, and stasis dermatitis from CVI, combined with pale wound bed areas, severe nocturnal rest pain, and trophic skin changes from PAD.

The central management dilemma in mixed ulcers revolves around compression therapy. While high compression is the mainstay for healing venous ulcers, applying un-modified compression to an ischemic leg can obliterate remaining arterial blood flow, causing skin necrosis, acute arterial thrombosis, or limb loss.

ABI Stratification for Compression Therapy:
ABI > 1.30      -> Non-compressible vessels; order TBI / TcPO2 before compression
ABI 0.81 - 1.30 -> Standard High Compression (30 - 40 mmHg) SAFE
ABI 0.50 - 0.80 -> Mixed Etiology; Modified Low-Pressure Compression (20 - 30 mmHg)
ABI < 0.50      -> Severe Arterial Ischemia; Compression ABSOLUTELY CONTRAINDICATED

ABI Safety Stratification Guidelines

Candidates must memorize the exact ABI cutoff values governing compression therapy safety:

• ABI 0.81 – 1.30 (Normal Arterial Perfusion): Standard high-pressure multi-layer compression (30–40 mmHg at the ankle) is safe and recommended.
• ABI 0.50 – 0.80 (Mixed Venous-Arterial Disease): Reduced arterial perfusion. Standard high compression is unsafe. However, modified low-pressure compression (20–30 mmHg) can be safely applied under close clinical supervision to manage edema while preserving minimal arterial inflow.
• ABI < 0.50 (Severe Ischemia / CLTI): Compression therapy is strictly contraindicated. Applying compression wraps or garments at this pressure level can induce rapid focal pressure necrosis and limb threat. Urgent vascular surgical referral for revascularization is mandated.

---

Lymphedema Pathophysiology & Etiology

Lymphedema is a chronic, progressive disease caused by primary aplasia/hypoplasia or secondary damage to the lymphatic transport system, resulting in accumulation of protein-rich interstitial fluid in the subcutaneous tissues.

Pathophysiological Cascade

Unlike venous edema (which is low-protein fluid), lymphatic fluid is rich in high-molecular-weight proteins, glycosaminoglycans, and cellular debris. The persistent stagnation of protein-rich fluid triggers a destructive cellular cascade:

1. Interstitial Fluid Accumulation: Lymphatic drainage failure causes high-protein fluid stasis in dermis and hypodermis.
2. Inflammatory & Fibroblastic Activation: High protein concentration stimulates chronic macrophage activation, recruitment of fibroblasts, and massive collagen deposition.
3. Adipogenesis & Sclerosis: Chronic tissue inflammation induces progressive subcutaneous adipose tissue hypertrophy (fat deposition) and irreversible dermal induration (woody sclerosis).

Lymphatic Transport Failure -> Accumulation of Protein-Rich Interstitial Fluid
  -> Macrophage Activation & Chronic Inflammation -> Fibroblast Recruitment & Collagen Deposition
  -> Subcutaneous Adipogenesis & Dermal Sclerosis -> Non-Pitting Edema, Papillomatosis & Elephantiasis

Primary vs. Secondary Lymphedema

• Primary Lymphedema: Caused by developmental dysplasias (aplasia, hypoplasia, or hyperplasia) of lymphatic vessels. Categorized by age of onset: Congenital lymphedema (present at birth or < 2 years, e.g., Milroy disease), Lymphedema praecox (develops during puberty/before age 35, e.g., Meige disease; accounts for 80% of primary cases), and Lymphedema tarda (develops after age 35).
• Secondary Lymphedema: Caused by acquired damage or obstruction of lymphatics. Globally, the leading cause is filariasis (parasitic infection by Wuchereria bancrofti). In developed nations, the leading causes are surgical lymph node excision (oncologic dissections), radiation therapy, recurrent cellulitis/erysipelas, severe trauma, morbid obesity, and chronic venous insufficiency.

---

Clinical Diagnosis & Cutaneous Manifestations

Lymphedema exhibits distinct physical exam signs and skin changes that differentiate it from acute or uncomplicated venous edema.

The Stemmer Sign

Stemmer Sign (also referred to as Kaposi-Stemmer sign) is the single most important diagnostic bedside test for lymphedema:

• Technique: The examiner attempts to pinch and lift a fold of skin at the dorsal base of the second toe (or second finger).
• Positive Test: The skin fold cannot be pinched or lifted due to severe subcutaneous fibrotic thickening and induration.
• Clinical Significance: A positive Stemmer sign is pathognomonic for lymphedema. A negative test does not completely rule out early Stage I lymphedema, but a positive test confirms lymphatic involvement.

Cutaneous Changes & Staging

As lymphedema progresses, the clinical character of the swelling transitions from pitting to non-pitting, accompanied by striking skin changes:

• Pitting vs. Non-Pitting Edema: Early lymphedema (Stage I) is pitting and decreases with elevation. Advanced lymphedema (Stage II and III) becomes non-pitting as fluid is replaced by fibrotic tissue and fat.
• Papillomatosis: Development of pebble-like, hyperkeratotic, warty projections and cobble-stone excrescences on the dermal surface, caused by dermal lymphatic ectasia and epidermal hyperplasia.
• Elephantiasis Nostras Verrucosa (ENV): The end-stage clinical manifestation (Stage III) characterized by massive limb enlargement, woody induration, deep skin folds, hyperkeratosis, and warty verrucous plaques. ENV poses extreme risks for recurrent bacterial infections (cellulitis, lymphangitis).

Lymphedema Stage Progression:
Stage 0 (Latent): Subclinical fluid stasis; no visible swelling
Stage I (Mild): Reversible pitting edema; decreases with leg elevation
Stage II (Moderate): Irreversible non-pitting edema; fibrotic tissue proliferation; positive Stemmer sign
Stage III (Severe): Elephantiasis Nostras Verrucosa; massive swelling, papillomatosis, deep skin folds

---

Phlebolymphedema

Phlebolymphedema represents a dual-etiology swelling state resulting from long-standing, severe chronic venous insufficiency that secondary damages the lymphatic system.

• Mechanism: Sustained ambulatory venous hypertension forces massive fluid overload into the interstitial tissues. Initially, the lymphatic system accelerates its pumping rate to clear the fluid. Over years, this chronic lymphatic overload induces mechanical exhaustion, lymphatic vessel dilation, valvular incompetence of lymphatics, and fibrotic sclerosis of lymph nodes.
• Clinical Features: Patients exhibit a hybrid presentation of both CVI and lymphedema: severe leg enlargement, hemosiderin pigmentation, stasis dermatitis, active or healed ulcers, positive Stemmer sign, and dorsum-of-foot swelling with papillomatosis.

---

Management Principles & Complete Decongestive Therapy (CDT)

The standard of care for lymphedema management is Complete Decongestive Therapy (CDT)—an intensive multi-modal physical treatment program divided into two phases:

Clinical Note: Short-stretch compression bandages are mandatory during decongestion because they provide high working pressure (resistance during calf muscle contraction) and low resting pressure, effectively driving lymphatic fluid out of tissues without occluding low-pressure lymphatic vessels during rest. Long-stretch elastic bandages (Ace wraps) are contraindicated as they exert high resting pressure and low working pressure.